"It looks like they used a reduced dose to test this indication with lesser side effect risk. Immune adaptive mutations occur typically in epitopes, both class I as well as class II. A viral protein is only visible to the t cell syste..."
Are you sure you want to delete your ?
You will no longer be able to add new data to this tracker.